E1100: A Phase I/II Trial of Herceptin and ZD1839 (Iressa, NSC #715055, IND#61187) in Patients with Metastatic Breast Cancer that Overexpresses HER2/neu(erbB-2)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/01 → 9/30/14

Funding

  • Frontier Science and Technology Research Foundation (E1100 / PCBCRFM09 // E1100 / PCBCRFM09)
  • Breast Cancer Research Foundation (E1100 / PCBCRFM09 // E1100 / PCBCRFM09)